The Impact of Sacrubitril/Valsartan on Clinical Treatment and hs-cTnT and NT-ProBNP Serum Levels and the Left Ventricular Function in Patients with Chronic Heart Failure

Author:

Gao Yang1,Xing Changtai2,Hao Wenjun1,Zhao Hongwei1,Wang Lili1,Luan Bo1,Hou Aijie1

Affiliation:

1. Department of Cardiology, The People's Hospital of Liaoning Province

2. Department of Cardiology, The Center Hospital Affiliated to Shenyang Medical College

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference23 articles.

1. 1. Aleksandrova EB, Sidorenko BA. Brain natriuretic peptide for early diagnosis of chronic heart failure in patients with preserved left ventricular ejection fraction. Kardiologiia 2012; 52: 27-32.

2. 2. Ji CL, Nomi A, Li B, Shen C, Song BC, Zhang JG. Increased plasma soluble fractalkine in patients with chronic heart failure and its clinical significance. Int Heart J 2019; 60: 701-7.

3. 3. Loretta Fala. Entresto (Sacubitril/Valsartan): first-in-class angiotensin receptor neprilysin inhibitor FDA approved for heart failure. Am Health Drug Benefits 2016; 3: 78-82.

4. 4. Tian H-P, Sun Y-H, He L, Yi YF, Gao X, Xu DL. Single-stranded DNA-binding Protein 1 abrogates cardiac fibroblast proliferation and collagen expression induced by angiotensin II. Int Heart J 2018; 59: 1398-408.

5. 5. McMurray J, Packer M, Desai A, et al. A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure. Eur Heart J 2015; 36: 434-9.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3